{
      "StudyFieldsResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:10:06 23:25:58.836",
            "Expression": "mesenchymal Longeveron",
            "NStudiesAvail": 430108,
            "NStudiesFound": 8,
            "MinRank": 1,
            "MaxRank": 1000,
            "NStudiesReturned": 8,
            "FieldList": [
                  "BriefSummary",
                  "BriefTitle",
                  "CentralContactEMail",
                  "CentralContactName",
                  "CentralContactPhone",
                  "CentralContactPhoneExt",
                  "CentralContactRole",
                  "CollaboratorClass",
                  "CollaboratorName",
                  "CompletionDate",
                  "CompletionDateType",
                  "Condition",
                  "ConditionAncestorId",
                  "ConditionAncestorTerm",
                  "ConditionBrowseBranchAbbrev",
                  "NCTId"
            ],
            "StudyFields": [
                  {
                        "Rank": 1,
                        "BriefSummary": [
                              "This is a randomized, placebo-controlled, double-blind, parallel arm, multi-center Phase 2b study."
                        ],
                        "BriefTitle": [
                              "Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "September 30, 2021"
                        ],
                        "CompletionDateType": [
                              "Actual"
                        ],
                        "Condition": [
                              "Aging Frailty"
                        ],
                        "ConditionAncestorId": [
                              "D000010335"
                        ],
                        "ConditionAncestorTerm": [
                              "Pathologic Processes"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC23",
                              "All"
                        ],
                        "NCTId": [
                              "NCT03169231"
                        ]
                  },
                  {
                        "Rank": 2,
                        "BriefSummary": [
                              "This is a phase I/II, randomized, blinded and placebo-controlled study to test the safety and efficacy of Lomecel-B for improving vaccine immune response."
                        ],
                        "BriefTitle": [
                              "Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "June 2022"
                        ],
                        "CompletionDateType": [
                              "Actual"
                        ],
                        "Condition": [
                              "Aging Frailty"
                        ],
                        "ConditionAncestorId": [
                              "D000010335"
                        ],
                        "ConditionAncestorTerm": [
                              "Pathologic Processes"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC23",
                              "All"
                        ],
                        "NCTId": [
                              "NCT02982915"
                        ]
                  },
                  {
                        "Rank": 3,
                        "BriefSummary": [
                              "This is a Phase I, prospective, randomized, placebo-controlled, double-blinded study designed to test the safety and efficacy of LMSCs (Longeveron Mesenchymal Stem Cells) for the treatment of subjects with clinically diagnosed Alzheimer's disease."
                        ],
                        "BriefTitle": [
                              "Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "September 2021"
                        ],
                        "CompletionDateType": [
                              "Actual"
                        ],
                        "Condition": [
                              "Alzheimer's Disease"
                        ],
                        "ConditionAncestorId": [
                              "D000003704",
                              "D000001927",
                              "D000002493",
                              "D000009422",
                              "D000024801",
                              "D000019636",
                              "D000019965",
                              "D000001523"
                        ],
                        "ConditionAncestorTerm": [
                              "Dementia",
                              "Brain Diseases",
                              "Central Nervous System Diseases",
                              "Nervous System Diseases",
                              "Tauopathies",
                              "Neurodegenerative Diseases",
                              "Neurocognitive Disorders",
                              "Mental Disorders"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC10",
                              "BXM",
                              "All",
                              "Rare"
                        ],
                        "NCTId": [
                              "NCT02600130"
                        ]
                  },
                  {
                        "Rank": 4,
                        "BriefSummary": [
                              "This study is designed to assess the safety, tolerability, and efficacy of Lomecel-B as an adjunct therapy to the standard stage II (BDCPA) surgical intervention for HLHS. Lomecel-B will be delivered via intramyocardial injections"
                        ],
                        "BriefTitle": [
                              "Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "December 31, 2021"
                        ],
                        "CompletionDateType": [
                              "Actual"
                        ],
                        "Condition": [
                              "HLHS"
                        ],
                        "ConditionAncestorId": [
                              "D000006330",
                              "D000018376",
                              "D000002318",
                              "D000006331",
                              "D000000013"
                        ],
                        "ConditionAncestorTerm": [
                              "Heart Defects, Congenital",
                              "Cardiovascular Abnormalities",
                              "Cardiovascular Diseases",
                              "Heart Diseases",
                              "Congenital Abnormalities"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC23",
                              "All",
                              "BC14",
                              "BC16",
                              "Rare"
                        ],
                        "NCTId": [
                              "NCT03525418"
                        ]
                  },
                  {
                        "Rank": 5,
                        "BriefSummary": [
                              "This is a phase 2b, randomized, placebo-controlled clinical trial designed to evaluate the safety and efficacy of Longeveron Mesenchymal Stem Cells (LMSCs) in subjects with metabolic syndrome and to assess the effects of LMSCs on endothelial function using several different doses."
                        ],
                        "BriefTitle": [
                              "Safety and Efficacy Trial Using Allogeneic Human Mesenchymal Stem Cells: The SIRONA Trial"
                        ],
                        "CentralContactEMail": [
                              "aoliva@longeveron.com",
                              "kramdas@longeveron.com"
                        ],
                        "CentralContactName": [
                              "Anthony Oliva, PhD",
                              "Kevin Ramdas, MD MPH"
                        ],
                        "CentralContactPhone": [
                              "(305) 909-0840",
                              "(305) 909-0840"
                        ],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [
                              "Contact",
                              "Contact"
                        ],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "December 2023"
                        ],
                        "CompletionDateType": [
                              "Anticipated"
                        ],
                        "Condition": [
                              "Metabolic Disease",
                              "Endothelial Dysfunction"
                        ],
                        "ConditionAncestorId": [],
                        "ConditionAncestorTerm": [],
                        "ConditionBrowseBranchAbbrev": [
                              "BC18",
                              "All",
                              "BC23"
                        ],
                        "NCTId": [
                              "NCT02587572"
                        ]
                  },
                  {
                        "Rank": 6,
                        "BriefSummary": [
                              "This study is intended to evaluate the safety and feasibility of intramyocardial injection of allogeneic mesenchymal cells during the Bi-Directional Cavopulmonary Anastomosis (BDCPA) surgery for hypoplastic left heart syndrome (HLHS) pediatric patients."
                        ],
                        "BriefTitle": [
                              "Allogeneic hMSC Injection in Patients With Hypoplastic Left Heart Syndrome"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "March 2019"
                        ],
                        "CompletionDateType": [
                              "Actual"
                        ],
                        "Condition": [
                              "Hypoplastic Left Heart Syndrome"
                        ],
                        "ConditionAncestorId": [
                              "D000004194",
                              "D000010335",
                              "D000006330",
                              "D000018376",
                              "D000002318",
                              "D000006331",
                              "D000000013"
                        ],
                        "ConditionAncestorTerm": [
                              "Disease",
                              "Pathologic Processes",
                              "Heart Defects, Congenital",
                              "Cardiovascular Abnormalities",
                              "Cardiovascular Diseases",
                              "Heart Diseases",
                              "Congenital Abnormalities"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC23",
                              "All",
                              "BC14",
                              "BC16",
                              "Rare"
                        ],
                        "NCTId": [
                              "NCT02398604"
                        ]
                  },
                  {
                        "Rank": 7,
                        "BriefSummary": [
                              "A Phase I, double- blinded, randomized, placebo- controlled study to test the safety of Lomecel-B in Adults suffering from mild to severe acute respiratory distress syndrome (ARDS) due to COVID-19 resultant from 2019-nCoV coronavirus infection, or resultant from influenza virus infection."
                        ],
                        "BriefTitle": [
                              "Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Lomecel-B (RECOVER)"
                        ],
                        "CentralContactEMail": [
                              "kramdas@longeveron.com",
                              "aoliva@longeveron.com"
                        ],
                        "CentralContactName": [
                              "Kevin N Ramdas, MD, MPH",
                              "Anthony Oliva, PhD"
                        ],
                        "CentralContactPhone": [
                              "786-769-4935",
                              "305-909-0838"
                        ],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [
                              "Contact",
                              "Contact"
                        ],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "July 2025"
                        ],
                        "CompletionDateType": [
                              "Anticipated"
                        ],
                        "Condition": [
                              "ARDS, Human",
                              "Covid19"
                        ],
                        "ConditionAncestorId": [
                              "D000012141",
                              "D000007239",
                              "D000011024",
                              "D000011014",
                              "D000014777",
                              "D000018352",
                              "D000003333",
                              "D000030341",
                              "D000012327",
                              "D000008171",
                              "D000012140",
                              "D000012120"
                        ],
                        "ConditionAncestorTerm": [
                              "Respiratory Tract Infections",
                              "Infections",
                              "Pneumonia, Viral",
                              "Pneumonia",
                              "Virus Diseases",
                              "Coronavirus Infections",
                              "Coronaviridae Infections",
                              "Nidovirales Infections",
                              "RNA Virus Infections",
                              "Lung Diseases",
                              "Respiratory Tract Diseases",
                              "Respiration Disorders"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC01",
                              "BC08",
                              "All",
                              "BC23",
                              "BC16",
                              "Rare"
                        ],
                        "NCTId": [
                              "NCT04629105"
                        ]
                  },
                  {
                        "Rank": 8,
                        "BriefSummary": [
                              "The purpose of this study is to look at the safety of treatment with stem cells in patients with Frailty."
                        ],
                        "BriefTitle": [
                              "AllogeneiC Human Mesenchymal Stem Cells (hMSC) in Patients With Aging FRAilTy Via IntravenoUS Delivery"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [
                              "INDUSTRY"
                        ],
                        "CollaboratorName": [
                              "The Emmes Company, LLC"
                        ],
                        "CompletionDate": [
                              "October 2, 2020"
                        ],
                        "CompletionDateType": [
                              "Actual"
                        ],
                        "Condition": [
                              "Frailty"
                        ],
                        "ConditionAncestorId": [
                              "D000010335"
                        ],
                        "ConditionAncestorTerm": [
                              "Pathologic Processes"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC23",
                              "All"
                        ],
                        "NCTId": [
                              "NCT02065245"
                        ]
                  }
            ]
      }
}